The treatment of the Parkinson's syndrome with special reference to the value of aturbane.
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central / Q000628:therapy*; D010300:Parkinson Disease / Q000628:therapy*
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central
MUSCLE RELAXANTS/therapy; PARALYSIS AGITANS/therapy